Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders.
Gemma Olivé-CireraElianet FonsecaVerónica Cantarín-ExtremeraMaría Vázquez-LópezMaría Jiménez-LegidoVerónica González-ÁlvarezJuliana Ribeiro-ConstanteAna Camacho-SalasItxaso MartíRamon Cancho-CandelaMaría Jesús Martínez-GonzálezAlbert SaizThaís Armanguenull nullPublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
In this cohort of children with neuroimmunologic disorders, the frequency of COVID-19 was low and not affected by immunosuppressive therapies. The main risk factors for developing COVID-19 were having cohabitants with COVID-19 and low vitamin D levels.